Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia

NCT07199179 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07199179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07199179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Link Between Reduction of Suicide Ideation by Esketamine in Add-On and Initial Levels of Psychological Pain and Anhedonia
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Active, not recruiting
Start date
November 24, 2024
Completion date
November 24, 2025
Enrollment
456 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression - major depressive disorder, depression disorder, suicide